Cargando…
A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects
Despite the fact that multiple sclerosis (MS) and Alzheimer’s disease (AD) share common neuroimmunological features, interferon beta 1a (IFNβ1a), the well-established treatment for the prevention of disease progression and cognitive decline in MS patients, has never been used in AD. We evaluated the...
Autores principales: | Grimaldi, Luigi Maria Edoardo, Zappalà, Giuseppe, Iemolo, Francesco, Castellano, Anna Elisa, Ruggieri, Stefano, Bruno, Giuseppe, Paolillo, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931325/ https://www.ncbi.nlm.nih.gov/pubmed/24524367 http://dx.doi.org/10.1186/1742-2094-11-30 |
Ejemplares similares
-
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)
por: Centonze, Diego, et al.
Publicado: (2021) -
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022) -
A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer’s Disease and Mild Cognitive Impairment from Healthy Controls
por: Piscopo, Paola, et al.
Publicado: (2022) -
Dermoscopy of facial angiofibromas in Fitzpatrick II‐III phototype subjects affected by tuberous sclerosis complex
por: Lacarrubba, Francesco, et al.
Publicado: (2023) -
Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)